Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Trial of Adjuvant Chemotherapy With Standard Regimens, Cyclophosphamide, Methotrexate and Fluorouracil - (CMF) or Doxorubicin and Cyclophosphamide - (AC), Versus Capecitabine in Women 65 Years and Older With Node Positive or Node-Negative Breast Cancer
Brief Summary: RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and giving them in different ways after surgery may kill more tumor cells. It is not yet known which chemotherapy regimen is more effective in treating older women with breast cancer.

PURPOSE: This randomized phase III trial is studying different combination chemotherapy regimens to see how well they work in treating older women who have undergone surgery for breast cancer.


Options:
A: Arm Label: A (experimental group); Type: ACTIVE_COMPARATOR; Interventions: Drug: Epirubicin, Drug: Docetaxel, Drug: Capecitabine, Drug: Trastuzumab | Arm Label: B (control group); Type: ACTIVE_COMPARATOR; Interventions: Drug: Epirubicin, Drug: Docetaxel, Drug: Trastuzumab | Intervention Type: DRUG; Name: Epirubicin; Assigned to Arm(s): A (experimental group), B (control group) | Intervention Type: DRUG; Name: Docetaxel; Assigned to Arm(s): A (experimental group), B (control group) | Intervention Type: DRUG; Name: Capecitabine; Assigned to Arm(s): A (experimental group) | Intervention Type: DRUG; Name: Trastuzumab; Assigned to Arm(s): A (experimental group), B (control group)
B: Arm Label: Standard Chemotherapy; Type: ACTIVE_COMPARATOR; Interventions: Drug: Standard Treatment | Arm Label: Capecitabine; Type: EXPERIMENTAL; Interventions: Drug: capecitabine | Intervention Type: DRUG; Name: Standard Treatment; Assigned to Arm(s): Standard Chemotherapy | Intervention Type: DRUG; Name: capecitabine; Assigned to Arm(s): Capecitabine
C: Arm Label: Arm 1A: Docetaxel then AC; Type: ACTIVE_COMPARATOR; Interventions: Drug: cyclophosphamide, Drug: docetaxel, Drug: doxorubicin hydrochloride (Adriamycin) | Arm Label: Arm 1B Docetaxel + Bev then AC + Bev; Type: EXPERIMENTAL; Interventions: Biological: bevacizumab, Drug: cyclophosphamide, Drug: docetaxel, Drug: doxorubicin hydrochloride (Adriamycin) | Arm Label: Arm 2A: Docetaxel + Capecitabine then AC; Type: EXPERIMENTAL; Interventions: Drug: capecitabine, Drug: cyclophosphamide, Drug: docetaxel, Drug: doxorubicin hydrochloride (Adriamycin) | Arm Label: Arm 2B: Docetaxel + Cape + Bev then AC + Bev; Type: EXPERIMENTAL; Interventions: Biological: bevacizumab, Drug: capecitabine, Drug: cyclophosphamide, Drug: docetaxel, Drug: doxorubicin hydrochloride (Adriamycin) | Arm Label: Arm 3A: Docetaxel + Gem then AC; Type: EXPERIMENTAL; Interventions: Drug: cyclophosphamide, Drug: docetaxel, Drug: doxorubicin hydrochloride (Adriamycin), Drug: gemcitabine hydrochloride | Arm Label: Arm 3B: Docetaxel + Gem + Bev then AC + Bev; Type: EXPERIMENTAL; Interventions: Biological: bevacizumab, Drug: cyclophosphamide, Drug: docetaxel, Drug: doxorubicin hydrochloride (Adriamycin), Drug: gemcitabine hydrochloride | Intervention Type: BIOLOGICAL; Name: bevacizumab; Assigned to Arm(s): Arm 1B Docetaxel + Bev then AC + Bev, Arm 2B: Docetaxel + Cape + Bev then AC + Bev, Arm 3B: Docetaxel + Gem + Bev then AC + Bev | Intervention Type: DRUG; Name: capecitabine; Assigned to Arm(s): Arm 2A: Docetaxel + Capecitabine then AC, Arm 2B: Docetaxel + Cape + Bev then AC + Bev | Intervention Type: DRUG; Name: cyclophosphamide; Assigned to Arm(s): Arm 1A: Docetaxel then AC, Arm 1B Docetaxel + Bev then AC + Bev, Arm 2A: Docetaxel + Capecitabine then AC, Arm 2B: Docetaxel + Cape + Bev then AC + Bev, Arm 3A: Docetaxel + Gem then AC, Arm 3B: Docetaxel + Gem + Bev then AC + Bev | Intervention Type: DRUG; Name: docetaxel; Assigned to Arm(s): Arm 1A: Docetaxel then AC, Arm 1B Docetaxel + Bev then AC + Bev, Arm 2A: Docetaxel + Capecitabine then AC, Arm 2B: Docetaxel + Cape + Bev then AC + Bev, Arm 3A: Docetaxel + Gem then AC, Arm 3B: Docetaxel + Gem + Bev then AC + Bev | Intervention Type: DRUG; Name: doxorubicin hydrochloride (Adriamycin); Assigned to Arm(s): Arm 1A: Docetaxel then AC, Arm 1B Docetaxel + Bev then AC + Bev, Arm 2A: Docetaxel + Capecitabine then AC, Arm 2B: Docetaxel + Cape + Bev then AC + Bev, Arm 3A: Docetaxel + Gem then AC, Arm 3B: Docetaxel + Gem + Bev then AC + Bev | Intervention Type: DRUG; Name: gemcitabine hydrochloride; Assigned to Arm(s): Arm 3A: Docetaxel + Gem then AC, Arm 3B: Docetaxel + Gem + Bev then AC + Bev
D: Arm Label: A Bev+Pac; Type: ACTIVE_COMPARATOR; Interventions: Biological: Bevacizumab and Paclitaxel | Arm Label: B Bev+Cap; Type: ACTIVE_COMPARATOR; Interventions: Biological: Bevacizumab and Capecitabine | Intervention Type: BIOLOGICAL; Name: Bevacizumab and Paclitaxel; Assigned to Arm(s): A Bev+Pac | Intervention Type: BIOLOGICAL; Name: Bevacizumab and Capecitabine; Assigned to Arm(s): B Bev+Cap

Answer: B